The acute toxicity of local anesthetics

Expert Opinion on Drug Metabolism and Toxicology

Volumn 6, Issue 11, 2010, Pages 1313-1332

  Mather, Laurence E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

acute toxicity; cardiovascular system; chemical properties; CNS; experimental models; local anesthetics; pharmacokinetic properties

Indexed keywords

ANALGESIC AGENT; ARTICAINE; BENZOCAINE; BUPIVACAINE; CHLOROPROCAINE; CINCHOCAINE; COCAINE; CYCLODEXTRIN; ETIDOCAINE; LEVOBUPIVACAINE; LIDOCAINE; LIPOSOME; LOCAL ANESTHETIC AGENT; MEPIVACAINE; PRILOCAINE; PROCAINE; ROPIVACAINE; TETRACAINE; VASOCONSTRICTOR AGENT;

ACUTE TOXICITY; CARDIOTOXICITY; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM DEPRESSION; CHIRALITY; CIRCUMORAL PARESTHESIA; COMA; CONVULSION; DIZZINESS; DRUG ABSORPTION; DRUG ELIMINATION; DRUG FATALITY; DRUG HALF LIFE; DRUG POTENCY; EXCITOTOXICITY; EXTRASYSTOLE; GENERAL ANESTHESIA; HEART ARRHYTHMIA; HEART CONTRACTION; HEART DEATH; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART OUTPUT; HEART VENTRICLE TACHYCARDIA; HUMAN; LIPOPHILICITY; MUSCLE HYPERTONIA; MUSCLE TWITCH; MYOCARDIAL DEPRESSION; NEUROMUSCULAR BLOCKING; NONHUMAN; PHYSICAL CHEMISTRY; QRS COMPLEX; RESPIRATION DEPRESSION; RESPIRATORY ARREST; REVIEW; SEIZURE; SHOCK; SIDE EFFECT; STEREOCHEMISTRY; TINNITUS; UNCONSCIOUSNESS; VISUAL DISORDER;

ACUTE TOXICITY TESTS; AMIDES; ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; HUMANS;

ANIMALIA; OVIS ARIES;

EID: 77958495111     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425255.2010.514265     Document Type: Review

References (151)

1. Cousins MJ, Carr DB, Horlocker TT, et al., editors. Neural Blockade in Clinical Anesthesia and Pain Medicine. 4th edition. Wolters Kluwer, Lippincott Williams & Wilkins, Philadelphia; 2008. p. 1-1306
2. Strichartz GR, Pastjin E, Sugimoto K. Neural physiology and local anesthetic action. In: Cousins MJ, Carr DB, Horlocker TT, et al., editors, Neural blockade in clinical anesthesia and pain medicine. 4th edition. Wolters Kluwer: Lippincott Williams & Wilkins, Philadelphia; 2008. p. 26-47
3. Drasner K. Local anesthetic neurotoxicity: clinical injury and strategies that may minimize risk. Reg Anesth Pain Med 2002;27:576-580
4. Zink W, Sinner B, Zausig Y, et al. Myotoxicity of local anaesthetics: experimental myth or clinical truth? Anaesthesist 2007;56:118-127
5. Boren E, Teuber SS, Naguwa SM, et al. A critical review of local anesthetic sensitivity. Clin Rev Allergy Immunol 2007;32:119-128
6. Guay J. Methemoglobinemia related to local anesthetics: a summary of 242 episodes. Anesth Analg 2009;108:837-845
7. Brown DJ, Fink BR. The history of regional anesthesia. In: Cousins MJ, Carr DB, Horlocker TT, et al., editors, Neural blockade in clinical anesthesia and pain medicine. 4th edition. Wolters Kluwer: Lippincott Williams & Wilkins, Philadelphia; 2008. p. 1-23
8. Weiniger CF, Golovanevski M, Sokolsky-Papkov M, et al. Review of prolonged local anesthetic action. Expert Opin Drug Deliv 2010;7:737-752
9. de-Paula E, Schreier S. Molecular and physicochemical aspects of local anesthetic-membrane interaction. Braz J Med Biol Res 1996;29:877-894
10. Malheiros SV, Pinto LM, Gottardo L, et al. A new look at the hemolytic effect of local anesthetics, considering their real membrane/water partitioning at pH 7.4. Biophys Chem 2004;110:213-221
11. Ruetsch YA, Boni T, Borgeat A. From cocaine to ropivacaine: the history of local anesthetic drugs. Curr Topics Med Chem 2001;1:175-182
12. Luduena FP. Toxicity and irritancy of local anesthetics. In: Lechat P, editor, Local anesthetics, Section 8. (Volume 1). International encyclopedia of pharmacology and therapeutics. Pergamon Press, New York; 1971. p. 319-341
13. Strichartz GR, Sanchez V, Arthur GR, et al. Fundamental properties of local anesthetics. II. Measured octanol:buffer partition coefficients and pKa values of clinically used drugs. Anesth Analg 1990;71:158-170
14. Grouls RJ, Ackerman EW, Korsten HH, et al. Partition coefficients (n-octanol/ water) of N-butyl-p-aminobenzoate and other local anesthetics measured by reversed-phase high-performance liquid chromatography. J Chromatogr B 1997;694:421-425
15. Rosenberg PH, Kytta J, Alila A. Uptake of bupivacaine, etidocaine, lignocaine and ropivacaine in n-heptane, rat sciatic nerve and human epidural and subcutaneous fat. Br J Anaesth 1986;58:310-314
16. Langerman L, Basinath M, Grant GJ. The partition coefficient as a predictor of local anesthetic potency for spinal anesthesia: evaluation of five local anesthetics in a mouse model. Anesth Analg 1994;79:490-494
17. Afekenstam B. The effect of the structural variation on the local analgetic properties of the most commonly used groups of substances. Acta Anaesthesiol Scand 1966;25(Suppl):10-18
18. Aberg G, Dhuner KG, Sydnes G. Studies on the duration of local anaesthesia: structure/activity relationships in a series of homologous local anaesthetics. Acta Pharmacol Toxicol 1977;41:432-443
19. Luduena FP. Duration of local anaesthesia. Annu Rev Pharmacol 1969;9:503-520
20. de Paula E, Schreier S, Jarrell HC, et al. Preferential location of lidocaine and etidocaine in lecithin bilayers as determined by EPR, fluorescence and 2H NMR. Biophys Chem 2008;32:47-54
21. Tucker GT, Boyes RN, Bridenbaugh PO, et al. Binding of anilide-type local anesthetics in human plasma. I. Relationships between binding, physicochemical properties, and anesthetic activity. Anesthesiology 1970;33:287-303
22. Mather LE, Thomas J. Bupivacaine binding to plasma protein fractions. J Pharm Pharmacol 1978;30:653-654
23. de Paula E, Schreier S. Use of a novel method for determination of partition coefficients to compare the effect of local anesthetics on membrane structure. Biochim Biophys Acta 1995;1240:25-33
24. Pardo L, Blanck TJJ, Recio-Pinto E. The neuronal lipid membrane permeability was markedly increased by bupivacaine and mildly affected by lidocaine and ropivacaine. Eur J Pharmacol 2000;455:81-90
25. Tsuchiya H, Ueno T, Mizogami M, et al. Local anesthetics structure-dependently interact with anionic phospholipid membranes to modify the fluidity. Chem Biol Interact 2010;183:19-24
26. Rutten AJ, Mather LE, Plummer JL, et al. Postoperative course of plasma protein binding of lignocaine, ropivacaine and bupivacaine in sheep. J Pharm Pharmacol 1992;44:355-358
27. Friberger P, Aberg G. Some physicochemical properties of the racemates and the optically active isomers of two local anaesthetic compounds. Acta Pharm Suec 1971;8:361-364
28. Tsuchiya H, Mizogami M, Ueno T, et al. Interaction of local anaesthetics with lipid membranes under inflammatory acidic conditions. Inflammopharmacology 2007;15:164-170
29. Hemmings HC, Greengard P. Positively active - how local anesthetics work. Anesthesiology 2010;113:250-252
30. Af Ekenstam B, Egner B, Pettersson G. N-alkyl pyrrolidine and N-alkyl piperidine carboxylic acid amides. Acta Chem Scand 1957;11:1183-1190
31. Akerman SBA, Camougis G, Sandberg RV. Stereoisomerism and differential activity in excitation block by local anesthetics. Eur Pharmacol 1969;8:337-347
32. Aps C, Reynolds F. An intradermal study of the local anaesthetic and vascular effects of the isomers of bupivacaine. Br J Clin Pharmacol 1978;6:63-68
33. Rutten AJ, Mather LE, McLean CF. Tissue distribution of bupivacaine enantiomers in sheep. Chirality 1993;5:485-491
34. Vladimirov M, Nau C, Mok WM, et al. Potency of bupivacaine stereoisomers tested in vitro and in vivo: biochemical, electrophysiological, and neurobehavioral studies. Anesthesiology 2000;93:744-755
35. Tsuchiya H, Mizogami M. Membrane interactivity of charged local anesthetic derivative and stereoselectivity in membrane interaction of local anesthetic enantiomers. Loc Reg Anesth 2008:1:1-9
36. Aberg G. Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds. Acta Pharm Toxicol 1972;31:272-286
37. Luduena FP, Bogado EF, Tullar BF. Optical isomers of mepivacaine and bupivacaine. Arch Int Pharmacodyn Ther 1972;200:359-369
38. Akerman B. Hellberg IB, Trossvik C. Primary evaluation of the local anesthetic properties of the amino amide agent ropivacaine (LEA 103). Acta Anaesthesiol Scand 1988;32:571-577
39. Gennery B, Mather LE, Strichartz G. Levobupivacaine: new preclinical and clinical data. Semin Anesth 2000;19:132-148
40. Trachez MM, Zapata-Sudo G, Moreira OR, et al. Motor nerve blockade potency and toxicity of non-racemic bupivacaine in rats. Acta Anaesthesiol Scand 2005;49:66-71
41. Lloyd B. The chemical structure and nomenclature of the local anaesthetics. Br J Anaesth 1955;27:286-290
42. Mather LE, Cousins MJ. Local anaesthetics and their current clinical use. Drugs 1979;18:185-205
43. Mather LE, Tucker GT. Properties, absorption and disposition of local anesthetic agents. In: Cousins MJ, Carr DB, Horlocker TT, et al., editors, Neural blockade in clinical anesthesia and pain medicine. 4th edition. Wolters Kluwer: Lippincott Williams & Wilkins, Philadelphia; 2008. p. 45-95
44. Columb MO, D'Angelo R. Up-down studies: responding to dosing! Int J Obstet Anesth 2006;15:129-136
45. Camorcia M, Capogna G, Columb MO. Minimum local analgesic doses of ropivacaine, levobupivacaine, and bupivacaine for intrathecal labor analgesia. Anesthesiology 2005;102:646-650
46. White PF. Continuous infusion of 0.5% bupivacaine for local analgesia: what are "toxic" blood levels? Reg Anesth Pain Med 2006;31:184
47. Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med 2004;29:564-575
48. Tucker GT, Mather LE. Clinical pharmacokinetics of local anaesthetic agents. Clin Pharmacokinet 1979;4:241-278
49. Simon MJ, Veering BT, Stienstra R, et al. The systemic absorption and disposition of levobupivacaine 0.5% after epidural administration in surgical patients: a stable-isotope study. Eur J Anaesth 2004;21:460-470
50. Simon MJ, Veering BT, Vletter AA, et al. The effect of age on the systemic absorption and systemic disposition of ropivacaine after epidural administration. Anesth Analg 2006;102:276-282
51. Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 1979;51:285-287
52. Horlocker TT, Neal JM. One hundred years later, I can still make your heart stop and your legs weak: the relationship between regional anesthesia and local anesthetic toxicity. Reg Anesth Pain Med 2002;27:543-544
53. Mather LE, Chang DH-T. Cardiotoxicity with modern local anaesthetics - Is there a safer choice? Drugs 2001;61:333-342
54. Di Gregiorio G, Neal JM, Rosenquist RW, et al. Clinical presentation of local anesthetic systemic toxicity. Reg Anesth Pain Med 2010;35:181-187
55. Heavner JE. Cardiac toxicity of local anesthetics in the intact isolated heart model: a review. Reg Anesth Pain Med 2002;27:545-555
56. Groban L. Central nervous system and cardiac effects from long-acting amide local anesthetic toxicity in the intact animal model. Reg Anesth Pain Med 2003;28:3-11
57. Garfield JM, Gugino L. Central effects of local anesthetic agents. In: Strichartz GR, editor, Local anesthetics: handb. exp pharm. (Volume 81). Springer-Verlag, Berlin; 1987. p. 252-284
58. Scott DB. Evaluation of the toxicity of local anaesthetic agents in man. Br J Anaesth 1975;47:56-61
59. Covino BG. Toxicity and systemic effects of local anesthetic agents. In: Strichartz GR, editor, Local anesthetics: handb. exp pharm. (Volume 81). Springer-Verlag, Berlin; 1987. p. 187-212
60. Pitkanen M, Feldman HS, Arthur GR, et al. Chronotropic and inotropic effects of ropivacaine, bupivacaine, and lidocaine in the spontaneously beating and electrically paced isolated, perfused rabbit heart. Reg Anesth 1992;17:183-192
61. Gintant GA, Hoffman BF. The role of local anesthetic effects in the action of antiarrhythmic drugs. In: Strichartz GR, editor, Local anesthetics: handb. exp pharm. (Volume 81). Springer-Verlag, Berlin; 1987. p. 213-251
62. Guinet P, Estebe JP, Ratajczak-Enselme M, et al. Electrocardiographic and hemodynamic effects of intravenous infusion of bupivacaine, ropivacaine, levobupivacaine, and lidocaine in anesthetized ewes. Reg Anesth Pain Med 2009;34:17-23
63. Scott DB, Lee A, Fagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989;69:563-569
64. Knudsen K, Beckman Suurkula M, Blomberg S, et al. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 1997;78:507-514
65. Bardsley H, Gristwood R, Baker H, et al. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br J Clin Pharmacol 1998;46:245-249
66. Stewart J, Kellett N, Castro D. The central nervous system and cardiovascular effects of levobupivacaine and ropivacaine in healthy volunteers. Anesth Analg 2003;97:412-416
67. Drasner K. Local anesthetic systemic toxicity. A historical perspective. Reg Anesth Pain Med 2010;35:162-166
68. Butterworth JF IV. Models and mechanisms of local anesthetic cardiac toxicity. A review. Reg Anesth Pain Med 2010;35:167-176
69. Royse CF, Royse AG. The myocardial and vascular effects of bupivacaine, levobupivacaine, and ropivacaine using pressure volume loops. Anesth Analg 2005;101:679-687
70. David J-S, Ferretti C, Amour J, et al. Effects of bupivacaine, levobupivacaine and ropivacaine on myocardial relaxation. Can J Anesth 2007;54:208-217
71. Feldman HS, Arthur GR, Covino BG. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog. Anesth Analg 1989;69:794-801
72. Bruelle P, LeFrant JY, de La Coussaye JE, et al. Comparative electrophysiologic and hemodynamic effects of several amide local anesthetic drugs in anesthetized dogs. Anesth Analg 1996;82:648-656
73. Groban L, Deal DD, Vernon JC, et al. Does local anesthetic stereoselectivity or structure predict myocardial depression in anesthetized canines? Reg Anesth Pain Med 2002;27:460-468
74. Kim JT, Rhee KY, Bahk JH, et al. Continuous mixed venous oxygen saturation, not mean blood pressure, is associated with early bupivacaine cardiotoxicity in dogs. Can J Anaesth 2003;50:376-381
75. Bernards CM, Carpenter RL, Kenter ME, et al. Effect of epinephrine on central nervous system and cardiovascular system toxicity of bupivacaine in pigs. Anesthesiology 1989;71:711-717
76. Haasio J, Pitkanen MT, Kytta J, et al. Treatment of bupivacaine-induced cardiac arrhythmias in hypoxic and hypercarbic pigs with amiodarone or bretylium. Reg Anesth 1990;15:174-179
77. Heavner JE, Badgwell JM, Dryden CF, et al. Bupivacaine toxicity in lightly anesthetized pigs with respiratory imbalances plus or minus halothane. Reg Anesth 1995;20:20-26
78. Morrison SG, Dominguez JJ, Frascarolo P, et al. A comparison of the electrocardiographic cardiotoxic effects of racemic bupivacaine, levobupivacaine, and ropivacaine in anesthetized swine. Anesth Analg 2000;90:1308-1314
79. Lefrant JY, de La Coussaye JE, Ripart J, et al. The comparative electrophysiologic and hemodynamic effects of a large dose of ropivacaine and bupivacaine in anesthetized and ventilated piglets. Anesth Analg 2001;93:1598-1605
80. Morishima HO, Finster M, Pedersen H, et al. Pharmacokinetics of lidocaine in fetal and neonatal lambs and adult sheep. Anesthesiology 1979;50:431-436
81. Morishima HO, Pedersen H, Finster M, et al. Etidocaine toxicity in the adult, newborn, and fetal sheep. Anesthesiology 1983;58:342-346
82. Runciman WB, Mather LE, Ilsley AH, et al. A sheep preparation for studying interactions between blood flow and drug disposition. III: effects of general and spinal anaesthesia on regional blood flow and oxygen tensions. Br J Anaesth 1984;56:1247-1258
83. Rosen MA, Thigpen JW, Kotelko DM, et al. Bupivacaine-induced cardiotoxicity in hypoxic and acidotic sheep. Anesth Analg 1985;64:1089-1096
84. Kasten GW, Martin ST. Comparison of resuscitation of sheep and dogs after bupivacaine induced cardiovascular collapse. Anesth Analg 1986;65:1029-1032
85. Nancarrow C, Runciman WB, Mather LE, et al. The influence of acidosis on the distribution of lidocaine and bupivacaine into the myocardium and brain of the sheep. Anesth Analg 1987;66:925-935
86. Huang YF, Upton RN, Runciman WB. IV bolus administration of subconvulsive doses of lignocaine to conscious sheep: relationships between myocardial pharmacokinetics and pharmacodynamics. Br J Anaesth 1993;70:556-561
87. Mather LE, Ladd LA, Chang DHT, et al. The effects of imposed acid-base derangement on the cardio-activity and pharmacokinetics of bupivacaine and thiopental. Anesthesiology 2004;100:1447-1457
88. McMillen C. The sheep: an ideal model for biomedical research? ANZCAART News 2001;14:1-5
89. Runciman WB, Mather LE. Effects of anaesthesia on drug disposition. In: Feldman SA, Scurr CF, Paton W, editors, Mechanisms of action of drugs in anaesthetic practice. Edward Arnold, London; 1987. p. 87-122
90. Arthur GR, Feldman HS, Covino BG. Alterations in the pharmacokinetic properties of amide local anaesthetics following local anaesthetic induced convulsions. Acta Anaesth Scand 1988;32:522-529
91. Mather LE, Rutten AJ, Plummer JL. Pharmacokinetics of bupivacaine enantiomers in sheep: influence of dosage regimen and study design. J Pharmacokinet Biopharm 1994;22:481-498
92. Mather LE. Disposition of mepivacaine and bupivacaine enantiomers in the sheep. Br J Anaesth 1991;67:239-246
93. Morishima HO, Pedersen H, Finster M, et al. Bupivacaine toxicity in pregnant and nonpregnant ewes. Anesthesiology 1985;63:134-139
94. Santos AC, Arthur GR, Pedersen H, et al. Systemic toxicity of ropivacaine during ovine pregnancy. Anesthesiology 1991;75:137-141
95. Santos AC, DeArmas PI. Systemic toxicity of levobupivacaine, bupivacaine, and ropivacaine during continuous intravenous infusion to nonpregnant and pregnant ewes. Anesthesiology 2001;95:1256-1264
96. Santos AC, Arthur GR, Wlody D, et al. Comparative systemic toxicity of ropivacaine and bupivacaine in nonpregnant and pregnant ewes. Anesthesiology 1995;82:734-740
97. Ladd LA, Mather LE. Central effects index - a semi-quantitative method for assessment of CNS toxicity of local anaesthetic agents in sheep. J Pharmacol Toxicol Methods 2000;44:467-476
98. Upton RN, Zheng DA, Grant C, et al. Development and validation of a recirculatory physiological model of the myocardial concentrations of lignocaine after intravenous administration in sheep. J Pharm Pharmacol 2000;52:181-189
99. Rutten AJ, Nancarrow C, Mather LE, et al. Hemodynamic and central nervous system effects of intravenous bolus doses of lidocaine, bupivacaine, and ropivacaine in sheep. Anesth Analg 1989;69:291-299
100. Huang YF, Upton RN, Runciman WB. I.V. bolus administration of subconvulsive doses of lignocaine to conscious sheep: myocardial pharmacokinetics. Br J Anaesth 1993;70:326-332
101. Huang YF, Pryor ME, Mather LE, et al. Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg 1998;86:797-804
102. Nancarrow C, Rutten AJ, Runciman WB, et al. Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep. Anesth Analg 1989;69:276-283
103. Mazoit JX, Boico O, Samii K. Myocardial uptake of bupivacaine: II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart. Anesth Analg 1993;77:477-482
104. Chang DH, Ladd LA, Wilson KA, et al. Tolerability of large-dose intravenous levobupivacaine in sheep. Anesth Analg 2000;91:671-679
105. Valenzuela C, Snyders DJ, Bennett PB, et al. Stereoselective block of cardiac sodium channels by bupivacaine in guineapig ventricular myocytes. Circulation 1995;92:3014-3024
106. Valenzuela C, Delpon E, Tamkun MM, et al. Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers. Biophys J 1995;69:418-427
107. Valenzuela C, Delpon E, Franqueza L, et al. Effects of ropivacaine on a potassium channel (hKv1.5) cloned from human ventricle. Anesthesiology 1997;86:718-728
108. Chedid NG, Sudo RT, Aguiar MI, et al. Regulation of intracellular calcium by bupivacaine isomers in cardiac myocytes from Wistar rats. Anesth Analg 2006;102:792-798
109. Heavner JE. Cardiac dysrhythmias induced by infusion of local anesthetics into the lateral cerebral ventricle of cats. Anesth Analg 1986;65:133-138
110. Chang DH, Ladd LA, Copeland S, et al. Direct cardiac effects of intracoronary bupivacaine, levobupivacaine and ropivacaine in the sheep. Br J Pharmacol 2001;132:649-658
111. Ladd LA, Chang DH, Wilson K, et al. Effects of CNS site-directed carotid arterial infusions of bupivacaine, levobupivacaine and ropivacaine in sheep. Anesthesiology 2002;97:418-428
112. Thomas RD, Behbehani MM, Coyle DE, et al. Cardiovascular toxicity of local anesthetics: an alternative hypothesis. Anesth Analg 1986;65:444-450
113. Runciman WB, Myburgh JA, Upton RN, et al. Effects of anaesthesia on drug disposition. In: Feldman SA, Scurr CF, Paton W, editors, Mechanisms of action of drugs in anaesthetic practice. 2nd edition. Edward Arnold, London; 1993. p. 93-128
114. Bertrix L, Timour Q, Mazze RI, et al. Adverse interaction between bupivacaine and halothane on ventricular contractile force and intraventricular conduction in the dog. Anesth Analg 1991;73:434-440
115. Badgwell JM, Heavner JE, Kytta J. Bupivacaine toxicity in young pigs is age-dependent and is affected by volatile anesthetics. Anesthesiology 1990;73:297-303
116. Copeland SE, Ladd LA, Gu X-Q, et al. Effects of general anesthesia on the central nervous and cardiovascular system toxicity of local anesthetics. Anesth Analg 2008;106:1429-1439
117. Copeland SE, Ladd LA, Gu X-Q, et al. Effects of general anesthesia on whole body and regional pharmacokinetics of local anesthetics at toxic doses. Anesth Analg 2008;106:1440-1449
118. Mather LE, Copeland SE, Ladd LA. Acute toxicity of local anesthetics: underlying pharmacokinetic and pharmacodynamic concepts. Reg Anesth Pain Med 2005;30:553-566
119. Boer F. Drug handling by the lungs. Br J Anaesth 2003;91:50-60
120. Burm AGL, Van der Meer AD, Van Kleef JW, et al. Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate. Br J Clin Pharmacol 1994;38:125-129
121. Mather LE, Huang YF, Pryor ME, et al. Systemic and regional pharmacokinetics of bupivacaine and levobupivacaine in sheep. Anesth Analg 1998;86:805-811
122. Guay J. Adverse events associated with intravenous regional anesthesia (Bier block): a systematic review of complications. J Clin Anesth 2009;21:585-594
123. Fuzier R, Lapeyre-Mestre M, Samii K, et al. Adverse drug reactions to local anaesthetics. A review of the French pharmacovigilance database. Drug Saf 2009;32:345-356
124. Szypula K, Ashpole KJ, Bogod D, et al. Litigation related to regional anaesthesia: an analysis of claims against the NHS in England 1995-2007. Anaesthesia 2010;65:443-452
125. O'Donnell BD, Iohom G. Regional anesthesia techniques for ambulatory orthopedic surgery. Curr Opin Anaesthesiol 2008;21:723-728
126. Cheng GS, Choy LP, Ilfeld BM. Regional anesthesia at home. Curr Opin Anaesthesiol 2008;21:488-493
127. Wright JL, Durieux ME, Groves DS. A brief review of innovative uses for local anesthetics. Curr Opin Anaesthesiol 2008;21:651-656
128. Hanna MN, Murphy JD, Kumar K, et al. Regional techniques and outcome: what is the evidence? Curr Opin Anaesthesiol 2009;22:672-677
129. Mulroy MF. Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures. Reg Anesth Pain Med 2002;27:556-561
130. Mulroy MMF, Hejtmanek MR. Prevention of Local anesthetic systemic toxicity. Reg Anesth Pain Med 2010;35:177-180
131. Neal JM, Bernards CM, Butterworth JF IV, et al. ASRA practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med 2010;35:152-161
132. D'Angelo R. Are the new local anesthetics worth their cost? Acta Anaesthesiol Scand 2000;44:639-641
133. Wildsmith JAW. New local anaesthetics - how much is improved safety worth? Acta Anaesthesiol Scand 2001;45:652-656
134. Barrington MJ, Watts SA, Gledhill SR, et al. Preliminary results of the Australasian Regional Anaesthesia Collaboration: a prospective audit of more than 7000 peripheral nerve and plexus blocks for neurologic and other complications. Reg Anesth Pain Med 2009;34:534-541
135. Nazir MS, Holdcroft A. Local anaesthetic drugs: adverse effects as reported through the ADROIT system in the UK. Pharmacoepidemiol Drug Saf 2009;18:1000-1006
136. Gristwood RW. Cardiac and CNS toxicity of levobupivacaine: strengths of evidence for advantage over bupivacaine. Drug Saf 2002;25:153-163
137. Whiteside JB, Wildsmith JAW. Developments in local anaesthetic drugs. Br J Anaesth 2001;87:27-35
138. Zink W, Graf BM. The toxicity of local anesthetics: the place of ropivacaine and levobupivacaine. Curr Opin Anaesthesiol 2008;21:645-650
139. Leone S, Di Cianni S, Casati A, et al. Pharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaine. Acta Biomed 2008;79:92-105
140. Vegha V, Cizmarika J, Hahnenkampb K. Is there a place for local anesthetics structurally different from classical amid or ester local anesthetics? Curr Opin Anaesthesiol 2006;19:509-515
141. Kohane D, Lu N, Gokgol-Kline A, et al. The local anesthetic properties and toxicity of saxitonin homologues for rat sciatic nerve block in vivo. Reg Anesth Pain Med 2000;25:52-59
142. Hogg RC. Novel approaches to pain relief using venom-derived peptides. Curr Med Chem 2006;13:3191-3201
143. McLeskey EW. A local route to pain relief. Nature 2007;449:545-546
144. Wiles MD, Nathanson MH. Local anaesthetics and adjuvants - future developments. Anaesthesia 2010;65(Suppl 1):22-37
145. Groban L, Deal DD, Vernon JC, et al. Cardiac resuscitation after incremental overdosage with lidocaine, bupivacaine, levobupivacaine, and ropivacaine in anesthetized dogs. Anesth Analg 2001;92:37-43
146. Harvey M, Cave G. Bupivacaine-induced cardiac arrest. Fat is good - is epinephrine really bad? Anesthesiology 2009;111:467-469
147. Hiller DB, Di Gregorio G, Ripper R, et al. Epinephrine impairs lipid resuscitation from bupivacaine overdose. A threshold effect. Anesthesiology 2009;111:498-505
148. Mazoit JX, Le Guen R, Beloeil H, Benhamou D. Binding of long-lasting local anesthetics to lipid emulsions. Anesthesiology 2009;110:380-386
149. Picard J, Ward SC, Zumpe R, et al. Guidelines and the adoption of 'lipid rescue' therapy for local anaesthetic toxicity. Anaesthesia 2009;64:122-125
150. Weinberg G. Treatment of local anesthetic systemic toxicity (LAST). Reg Anesth Pain Med 2010;35:188-193
151. Hiller DB, Di Gregorio G, Kelly K, et al. Safety of high volume lipid emulsion infusion. A first approximation of LD50 in rats. Reg Anesth Pain Med 2010;35:140-144